Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials-Reference-Cited by-同舟云学术

Organ at Risk Dose Constraints in SABR: A Systematic Review of Active Clinical Trials

Published:2021-07 Issue:4 Volume:11 Page:e355-e365
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Gerhard Serenna G.,Palma David A.^ORCID,Arifin Andrew J.,Louie Alexander V.,Li George J.,Al-Shafa Faiez,Cheung Patrick,Rodrigues George B.,Bassim Carol W.,Corkum Mark T.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference23 articles.

1. Stereotactic radiotherapy in oligometastatic cancer;Kennedy;Chinese Clin Oncol,2017

2. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-term results of the SABR-COMET phase II randomized trial;Palma;J Clin Oncol,2020

3. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: A multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol,2016

4. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: A phase 2 randomized clinical trial;Iyengar;JAMA Oncol,2018

5. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomized, multicenter phase II trial;Ost;J Clin Oncol,2018

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol;BMC Palliative Care;2024-09-07

3. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline;Practical Radiation Oncology;2024-09

4. Refining Treatment Planning in STereotactic Arrhythmia Radioablation: Benchmark Results and Consensus Statement From the STOPSTORM.eu Consortium;International Journal of Radiation Oncology*Biology*Physics;2024-08

5. A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients with Up to 10 Oligometastases and a Synchronous Primary Tumor (SABR-SYNC): Study Protocol;2024-06-27